"Selective" pituitary insufficiency secondary to busulfan.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000309:Adrenal Insufficiency / Q000139:chemically induced*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000368:Aged; D002066:Busulfan / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008797:Metyrapone / Q000494:pharmacology; D008875:Middle Aged; D010900:Pituitary Diseases / Q000139:chemically induced*; D010913:Pituitary-Adrenal System; D011087:Polycythemia Vera / Q000188:drug therapy; D055728:Primary Myelofibrosis / Q000188:drug therapy; D013156:Splenectomy; D013960:Thyroid Function Tests
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000324:Adrenocorticotropic Hormone; D002066:Busulfan; D008797:Metyrapone